Efficacy and safety of irreversible electroporation combined with immunotherapy in treatment of unresectable pancreatic cancer: A Meta-analysis

Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 11

Abstract

[Objective] To systematically review the safety and efficacy of irreversible electroporation (IRE) combined with immunotherapy in patients with unresectable pancreatic cancer. [Methods] This study was conducted according to the PRISMA guideline, with a PROSPERO registration unmber of CRD42024531984. Datebases including PubMed, Embase the Cochrane Library, Web of Science, CNKI, Wanfang Data, and VIP were searched for related articles on IRE combined with immunotherapy for unresectable pancreatic cancer published up to February 2024. The articles were screened and related data were extracted according to the established inclusion and exclusion criteria, and the quality of the articles was assessed. Review Manager 5.3 and Stata 17.0 software were used to perform the meta-analysis. [Results] Six studies were finally included, with three prospective studies, two retrospective studies, and one randomized controlled trial. There were 376 patients with unresectable pancreatic cancer in total, among whom there were 222 patients in the IRE group and 154 patients in the IRE+immunotherapy group. The meta-analysis showed that compared with IRE alone, IRE combined with immunotherapy significantly prolonged progression-free survival (hazard ratio [HR]=0.82, 95% confidence interval [CI]: 0.72 ‍—‍ 0.92, P=0.001) and overall survival (HR=0.86, 95%CI: 0.80 ‍—‍ 0.93, P=0.000 1), increased T lymphocyte count in the patients (mean difference=217.93, 95%CI: 192.87 ‍—‍ 242.99, P<0.000 01), and improved the immune function of patients. However, there were no significant differences between the two groups in reducing the incidence rate of adverse events (odds ratio [OR]=1.43, 95%CI: 0.76 ‍—‍ 2.72, P=0.27) and improving the objective remission rate of patients (OR=1.49, 95%CI: 0.87 ‍—‍ 2.56, P=0.15). [Conclusion] IRE combined with immunotherapy is safe and effective in patients with unresectable pancreatic cancer and can significantly improve overall survival and progression-free survival and enhance immune function, with little effect on objective remission rate and the incidence rate of adverse events.

Authors and Affiliations

Jian YE, Junfeng YANG, Liwen DU, Jiansheng LIU

Keywords

Related Articles

Regulatory effect of Kangxian Yiai Prescription in a rat model of precancerous lesions of liver cancer: A study based on the mTOR/HIF-1α/VEGF signaling pathway

[Objective] To investigate the effect of Kangxian Yiai Prescription (KXYA) on the mTOR/HIF-1α/VEGF signaling pathway in a rat model of precancerous lesions of liver cancer. [Methods] A total of 40 male Wistar rats were...

Effect of Bacillus licheniformis preparation on hepatic steatosis and intestinal mucosal barrier function in a rat model of nonalcoholic fatty liver disease

[Objective] To investigate the effects of Bacillus licheniformis on liver histopathology and intestinal mucosal barrier function in rats with nonalcoholic fatty liver disease(NAFLD). [Methods] A total of 30 male Spragu...

Experience in eliminating the mother-to-child transmission of hepatitis B virus in China

Reducing the mother-to-child transmission of hepatitis B virus (HBV) is crucial for achieving HBV elimination. Launched in July 2015 at the Great Hall of the People in Beijing, China, the “Zero Hepatitis B Mother-to-...

The role of endoplasmic reticulum stress in non-alcoholic fatty liver disease and related targeted therapies

Non-alcoholic fatty liver disease (NAFLD) is a series of diseases characterized by hepatic steatosis and is also a metabolism-associated disease and an important factor for liver fibrosis, liver cirrhosis, and hepato...

Role and mechanism of hepatic stellate cells in regulating the apoptosis of hepatocellular carcinoma cells through cystathionine γ-lyase/hydrogen sulfide

[Objective] As important components in the microenvironment of hepatocellular carcinoma (HCC), hepatic stellate cells (HSCs) and hydrogen sulfide (H2S) participate in various biological processes that regulate the...

Download PDF file
  • EP ID EP753502
  • DOI 10.12449/JCH241122
  • Views 19
  • Downloads 1

How To Cite

Jian YE, Junfeng YANG, Liwen DU, Jiansheng LIU (2024). Efficacy and safety of irreversible electroporation combined with immunotherapy in treatment of unresectable pancreatic cancer: A Meta-analysis. Journal of Clinical Hepatology, 40(11), -. https://europub.co.uk./articles/-A-753502